Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| HARVARD BIOSCIENCE INCHBIO · Entity 7369 | Director | May 21, 2024 | May 23, 2024 |
| THERMO FISHER SCIENTIFIC INC.TMO · Entity 2836 | Senior Vice President | August 28, 2017 | August 29, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
HARVARD BIOSCIENCE INC
Report date May 21, 2024 · Filed May 23, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 295,311 |
Reported balance
After 2024-05-21 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2024-05-21 · Grant · Acquired 45,872 · Balance 295,311 F1: Represents an award of 45,872 restricted stock units that fully vest on the earlier to occur of (i) the date of the Issuer's next Annual Meeting of Stockholders after May 14, 2024, immediately prior to the commencement of such meeting, and (ii) May 21, 2025. F2: Includes (a) the award described in footnote (1) above and (b) 249,439 shares of common stock held by the Reporting Person. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents an award of 45,872 restricted stock units that fully vest on the earlier to occur of (i) the date of the Issuer's next Annual Meeting of Stockholders after May 14, 2024, immediately prior to the commencement of such meeting, and (ii) May 21, 2025.
F2: Includes (a) the award described in footnote (1) above and (b) 249,439 shares of common stock held by the Reporting Person.
THERMO FISHER SCIENTIFIC INC.
Report date August 28, 2017 · Filed August 29, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 38,133 |
Reported balance
After 2017-08-28 transaction · row 1
1 source rowRow 1 · 2017-08-28 · Tax withholding · Disposed 410 · Balance 38,133 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 21, 2024 Filed May 23, 2024 20:23 UTC | HARVARD BIOSCIENCE INC HBIO · Entity 7369 | GrantCommon Stock | 45,872 | $0.00 | $0.00 |
DisclosureSEC source: 0000921895-24-001306 · form412799001loe_05232024.xml · nonDerivative · entry 1 Loewald Thomas W · CIK 0001538555 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 295,311 F1 · shares: Represents an award of 45,872 restricted stock units that fully vest on the earlier to occur of (i) the date of the Issuer's next Annual Meeting of Stockholders after May 14, 2024, immediately prior to the commencement of such meeting, and (ii) May 21, 2025. F2 · balance_after: Includes (a) the award described in footnote (1) above and (b) 249,439 shares of common stock held by the Reporting Person. Read SEC document |
| May 22, 2023 Filed May 23, 2023 20:04 UTC | HARVARD BIOSCIENCE INC HBIO · Entity 7369 | GrantCommon Stock | 25,554 | $0.00 | $0.00 |
DisclosureSEC source: 0000921895-23-001328 · form412799loe_05232023.xml · nonDerivative · entry 1 Loewald Thomas W · CIK 0001538555 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 249,439 F1 · shares: Represents an award of 25,554 restricted stock units that fully vest on the earlier to occur of (i) the date of the Issuer's next Annual Meeting of Stockholders after May 15, 2023, immediately prior to the commencement of such meeting, and (ii) May 22, 2024. F2 · balance_after: Includes (a) the award described in footnote (1) above and (b) 223,885 shares of common stock held by the Reporting Person. Read SEC document |
| May 24, 2022 Filed May 26, 2022 20:06 UTC | HARVARD BIOSCIENCE INC HBIO · Entity 7369 | GrantCommon Stock | 38,259 | $0.00 | $0.00 |
DisclosureSEC source: 0000921895-22-001803 · form412799001loe_05262022.xml · nonDerivative · entry 1 Loewald Thomas W · CIK 0001538555 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 223,885 F1 · shares: Represents an award of 38,259 restricted stock units that fully vest on the earlier to occur of (i) the date of the Issuer's next Annual Meeting of Stockholders after May 17, 2022, immediately prior to the commencement of such meeting, and (ii) May 24, 2023. F2 · balance_after: Includes (a) the award described in footnote (1) above and (b) 185,626 shares of common stock held by the Reporting Person. Read SEC document |
| January 01, 2022 Filed Jan 4, 2022 00:50 UTC | HARVARD BIOSCIENCE INC HBIO · Entity 7369 | GrantCommon Stock | 2,525 | $0.00 | $0.00 |
DisclosureSEC source: 0000921895-22-000033 · form412799loe_01032022.xml · nonDerivative · entry 1 Loewald Thomas W · CIK 0001538555 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 185,626 F1 · shares: Represents an award of 2,525 restricted stock units that will vest in full on the date of the Issuer's 2022 Annual Meeting of the Stockholders. F2 · balance_after: Includes (a) the award described in footnote (1) above, (b) an award of 14,400 restricted stock units that fully vest on the earlier to occur of (i) the date of the Issuer's next Annual Meeting of Stockholders after May 18, 2021, immediately prior to the commencement of such meeting, and (ii) May 25, 2022, and (c) 168,701 shares of common stock held by the Reporting Person. Read SEC document |
| December 28, 2021 Filed Dec 29, 2021 21:21 UTC | HARVARD BIOSCIENCE INC HBIO · Entity 7369 | GrantCommon Stock | 1,401 | $0.00 | $0.00 |
DisclosureSEC source: 0000921895-21-002901 · form412799001loe_12292021.xml · nonDerivative · entry 1 Loewald Thomas W · CIK 0001538555 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 183,101 F1 · shares: Represents an award of 1,401 restricted stock units that fully vest on December 31, 2021. F2 · balance_after: Includes (a) the award described in footnote (1) above, (b) an award of 14,400 restricted stock units that fully vest on the earlier to occur of (i) the date of the Issuer's next Annual Meeting of Stockholders after May 18, 2021, immediately prior to the commencement of such meeting, and (ii) May 25, 2022, (c) an award of 3,825 remaining unvested restricted stock units that fully vest on December 29, 2021, and (d) 163,475 shares of common stock held by the Reporting Person. Read SEC document |
| May 25, 2021 Filed May 27, 2021 20:21 UTC | HARVARD BIOSCIENCE INC HBIO · Entity 7369 | GrantCommon Stock | 14,400 | $0.00 | $0.00 |
DisclosureSEC source: 0000921895-21-001512 · form412799loe_05272021.xml · nonDerivative · entry 1 Loewald Thomas W · CIK 0001538555 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 181,700 F1 · shares: Represents an award of 14,400 restricted stock units that fully vest on the earlier to occur of (i) the date of the Issuer's next Annual Meeting of Stockholders after May 18, 2021, immediately prior to the commencement of such meeting, and (ii) May 25, 2022. F2 · balance_after: Includes (a) the award described in footnote (1) above, (b) an award of 11,475 remaining unvested restricted stock units vesting in equal quarterly installments on June 30, 2021, September 30, 2021 and December 31, 2021, and (c) 155,825 shares of common stock held by the Reporting Person. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 22:46 UTC | HARVARD BIOSCIENCE INC HBIO · Entity 7369 | GrantCommon Stock | 15,300 | $0.00 | $0.00 |
DisclosureSEC source: 0000921895-21-000051 · form412799loe_01062021.xml · nonDerivative · entry 1 Loewald Thomas W · CIK 0001538555 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 167,300 F1 · shares: Represents a deferred stock award of 15,300 restricted stock units which vest quarterly in equal installments on March 31, 2021, June 30, 2021, September 30, 2021 and December 31, 2021 and are subject to continued service as a non-employee director on the applicable vesting dates. These retainer awards are granted in satisfaction of the annual retainer compensation to be earned by the director for his service on the Issuer's Board of Directors and its Committees during 2021. The number of shares of common stock subject to such retainer award is equal to the amount of cash that would have been received had the applicable retainer all been paid in cash, divided by the average daily closing price of the Issuer's common stock for the month of November, rounded to the nearest 100 shares. F2 · balance_after: Includes (a) the award described in footnote (1) above, (b) an award of 28,100 restricted stock units that fully vest on the earlier to occur of (i) the date of the Issuer's next Annual Meeting of Stockholders after June 11, 2020, immediately prior to the commencement of such meeting, or (ii) June 18, 2021, and (c) 123,900 shares of common stock held by the Reporting Person. Read SEC document |
| June 18, 2020 Filed Jun 19, 2020 21:12 UTC | HARVARD BIOSCIENCE INC HBIO · Entity 7369 | GrantCommon Stock | 28,100 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-037990 · doc4.xml · nonDerivative · entry 1 Loewald Thomas W · CIK 0001538555 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,000 F1 · shares: Represents an award of 28,100 restricted stock units that fully vest on the earlier to occur of (i) the date of the Issuer's next Annual Meeting of Stockholders after June 11, 2020, immediately prior to the commencement of such meeting, and (ii) June 18, 2021. F2 · balance_after: Includes (a) the award described in footnote (1) above, (b) a restricted stock unit award of 15,525 remaining unvested restricted stock units vesting in equal quarterly installments on June 30, 2020, September 30, 2020 and December 31, 2020, and (c) 108,375 shares of common stock held by the Reporting Person. Read SEC document |
| January 02, 2020 Filed Jan 3, 2020 21:37 UTC | HARVARD BIOSCIENCE INC HBIO · Entity 7369 | GrantCommon Stock | 20,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-001043 · doc4.xml · nonDerivative · entry 1 Loewald Thomas W · CIK 0001538555 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,900 F1 · shares: Represents a deferred stock award of 20,700 restricted stock units which vest quarterly in equal installments on March 31, 2020, June 30, 2020, September 30, 2020 and December 31, 2020, and are subject to continued service as a non-employee director on the applicable vesting dates. These retainer awards are granted in satisfaction of the annual retainer compensation to be earned by the director for his service on the Issuer's Board of Directors and its Committees during 2020. The number of shares of common stock subject to such retainer award is equal to the amount of cash that would have been received had the applicable retainer all been paid in cash, divided by the average daily closing price of the Issuer's common stock for the month of November, rounded to the nearest 100 shares. F2 · balance_after: Includes (a) a deferred stock award of 20,700 restricted stock units which vest quarterly in equal installments on March 31, 2020, June 30, 2020, September 30, 2020 and December 31, 2020 as described in footnote 1 above, (b) a deferred stock award of 35,100 restricted stock units which fully vest on the earlier of (i) the date of the Issuer's next Annual Meeting of Stockholders after May 16, 2019, immediately prior to the commencement of such meeting, and (ii) May 23, 2020; and (c) 68,100 shares of common stock held by the Reporting Person. Read SEC document |
| August 20, 2019 Filed Aug 20, 2019 20:19 UTC | HARVARD BIOSCIENCE INC HBIO · Entity 7369 | PurchaseCommon Stock | 20,000 | $2.53 | $50,524.00 |
DisclosureSEC source: 0001209191-19-046799 · doc4.xml · nonDerivative · entry 1 Loewald Thomas W · CIK 0001538555 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,200 F1 · balance_after: Includes (a) a deferred stock award of 900 restricted stock units which vest quarterly in equal installments on September 30, 2019 and December 31, 2019 as described in footnote 1 above; (b) a deferred stock award of 35,100 restricted stock units which fully vest on the earlier of (i) the date of the Issuer's next Annual Meeting of Stockholders after May 16, 2019, immediately prior to the commencement of such meeting, and (ii) May 23, 2020; (c) a deferred stock award of 6,900 restricted stock units which vest quarterly in equal installments on September 30, 2019 and December 31, 2019; and (d) 60,300 shares of common stock held by the Reporting Person. Read SEC document |
| August 01, 2019 Filed Aug 1, 2019 20:19 UTC | HARVARD BIOSCIENCE INC HBIO · Entity 7369 | GrantCommon Stock | 900 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-044025 · doc4.xml · nonDerivative · entry 1 Loewald Thomas W · CIK 0001538555 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,200 F1 · shares: Represents a deferred stock award of 900 restricted stock units which vest quarterly in equal installments on September 30, 2019 and December 31, 2019. This retainer award was granted in lieu and satisfaction of the annual cash retainer compensation to be earned by the director for his service on a committee of the Issuer's Board of Directors that the reporting person was appointed to following the 2019 Annual Meeting of Stockholders. The number of shares of common stock subject to such retainer award is equal to the amount of cash that would have been received had the applicable retainer all been paid in cash, divided by the average daily closing market price of the Issuer's common stock for the month of May, rounded to the nearest 100 shares. F2 · balance_after: Includes (a) a deferred stock award of 900 restricted stock units which vest quarterly in equal installments on September 30, 2019 and December 31, 2019 as described in footnote 1 above; (b) a deferred stock award of 35,100 restricted stock units which fully vest on the earlier of (i) the date of the Issuer's next Annual Meeting of Stockholders after May 16, 2019, immediately prior to the commencement of such meeting, and (ii) May 23, 2020; (c) a deferred stock award of 6,900 restricted stock units which vest quarterly in equal installments on September 30, 2019 and December 31, 2019; and (d) 40,300 shares of common stock held by the Reporting Person. Read SEC document |
| May 23, 2019 Filed May 24, 2019 21:23 UTC | HARVARD BIOSCIENCE INC HBIO · Entity 7369 | GrantCommon Stock | 35,100 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-032787 · doc4.xml · nonDerivative · entry 1 Loewald Thomas W · CIK 0001538555 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,300 F1 · shares: Represents a deferred stock award of 35,100 restricted stock units which fully vest on the earlier to occur of (i) the date of the Issuer's next Annual Meeting of Stockholders after May 16, 2019, immediately prior to the commencement of such meeting, and (ii) May 23, 2020. F2 · balance_after: Includes (a) deferred stock award of 35,100 restricted stock units which fully vest on the earlier of (i) the date of the Issuer's next Annual Meeting of Stockholders after May 16, 2019, immediately prior to the commencement of such meeting, and (ii) May 23, 2020; (b) a deferred stock award of 10,350 restricted stock units which vest quarterly in equal installments on June 30, 2019, September 30, 2019 and December 31, 2019; and (c) 36,850 shares of common stock held by the Reporting Person. Read SEC document |
| January 02, 2019 Filed Jan 3, 2019 21:26 UTC | HARVARD BIOSCIENCE INC HBIO · Entity 7369 | GrantCommon Stock | 13,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-000952 · doc4.xml · nonDerivative · entry 1 Loewald Thomas W · CIK 0001538555 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,200 F1 · shares: Represents a deferred stock award of 13,800 restricted stock units which vest quarterly in equal installments on March 31, 2019, June 30, 2019, September 30, 2019 and December 31, 2019, and are subject to continued service as a non-employee director on the applicable vesting dates. These retainer awards are granted in satisfaction of the annual retainer compensation to be earned by the director for his service on the Issuer's Board of Directors and its Committees during 2019. The number of shares of common stock subject to such retainer award is equal to the amount of cash that would have been received had the retainers all been paid in cash, divided by the average daily closing market price of the Issuer's common stock for the month of November, rounded to the nearest 100 shares. F2 · balance_after: Includes (a) a deferred stock award of 13,800 restricted stock units which vest quarterly in equal installments on March 31, 2019, June 30, 2019, September 30, 2019 and December 31, 2019; a (b) deferred stock award of 18,100 restricted stock units which fully vest on the earlier of (i) the date of the Issuer's next Annual Meeting of Stockholders after May 17, 2018, immediately prior to the commencement of such meeting, and (ii) May 17, 2019; and (c) 15,300 shares of common stock held by the Reporting Person. Read SEC document |
| June 01, 2018 Filed Jun 5, 2018 20:23 UTC | HARVARD BIOSCIENCE INC HBIO · Entity 7369 | GrantCommon Stock | 1,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-035672 · doc4.xml · nonDerivative · entry 1 Loewald Thomas W · CIK 0001538555 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,400 F1 · shares: Represents a deferred stock award of 1,600 restricted stock units which vest quarterly in equal installments on June 30, 2018, September 30, 2018 and December 31, 2018. This retainer award was granted in lieu and satisfaction of the annual cash retainer compensation to be earned by the director for his service on a committee of the Issuer's Board of Directors that the reporting person was appointed to following the 2018 Annual Meeting of Stockholders. The number of shares of common stock subject to such retainer award is equal to the amount of cash that would have been received had the applicable retainer all been paid in cash, divided by the average daily closing market price of the Issuer's common stock for the month of March, rounded to the nearest 100 shares. F2 · balance_after: Includes (a) a deferred stock award of 1,600 restricted stock units which vest quarterly in equal installments on June 30, 2018, September 30, 2018 and December 31, 2018 as described in footnote 1 above; (b) a deferred stock award of 18,100 restricted stock units which fully vest on the earlier of (i) the date of the Issuer's next Annual Meeting of Stockholders after May 17, 2018, immediately prior to the commencement of such meeting; (c) a deferred stock award of 8,550 restricted stock units which vest quarterly in equal installments on June 30, 2018, September 30, 2018 and December 31, 2018; and (d) 5,150 shares of common stock held by the Reporting Person. Read SEC document |
| May 24, 2018 Filed May 29, 2018 20:47 UTC | HARVARD BIOSCIENCE INC HBIO · Entity 7369 | GrantCommon Stock | 18,100 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-033866 · doc4.xml · nonDerivative · entry 1 Loewald Thomas W · CIK 0001538555 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,800 F1 · shares: Represents a deferred stock award of 18,100 restricted stock units which fully vest on the earlier to occur of (i) the date of the Issuer's next Annual Meeting of Stockholders after May 17, 2018, immediately prior to the commencement of such meeting, and (ii) May 24, 2019. F2 · balance_after: Includes (a) a deferred stock award of 18,100 restricted stock units which fully vest on the earlier of (i) the date of the Issuer's next Annual Meeting of Stockholders after May 17, 2018, immediately prior to the commencement of such meeting, and (ii) May 17, 2019; (b) a deferred stock award of 8,550 restricted stock units which vest quarterly in equal installments on June 30, 2018, September 30, 2018 and December 31, 2018; and (c) 5,150 shares of common stock held by the Reporting Person. Read SEC document |
| January 02, 2018 Filed Jan 4, 2018 13:43 UTC | HARVARD BIOSCIENCE INC HBIO · Entity 7369 | GrantCommon Stock | 11,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-001620 · doc4.xml · nonDerivative · entry 1 Loewald Thomas W · CIK 0001538555 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,700 F1 · shares: Represents a deferred stock award of 11,400 restricted stock units which vest quarterly in equal installments on March 31, 2018, June 30, 2018, September 30, 2018 and December 31, 2018, and are subject to continued service as a non-employee director on the applicable vesting dates. These retainer awards are granted in lieu and satisfaction of the annual cash retainer compensation to be earned by the director for his service on the Issuer's Board of Directors and its Committees during 2018. The number of shares of common stock subject to such retainer award is equal to the amount of cash that would have been received had the retainers all been paid in cash, divided by the average daily closing market price of the Issuer's common stock for the month of November, rounded to the nearest 100 shares. F2 · balance_after: Includes (a) a deferred stock award of 11,400 restricted stock units which vest quarterly in equal installments on March 31, 2018, June 30, 2018, September 30, 2018 and December 31, 2018; and (b) 2,300 shares of common stock held by the Reporting Person. Read SEC document |
| November 01, 2017 Filed Nov 1, 2017 21:09 UTC | HARVARD BIOSCIENCE INC HBIO · Entity 7369 | GrantCommon Stock | 2,300 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-058644 · doc4.xml · nonDerivative · entry 1 Loewald Thomas W · CIK 0001538555 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,300 F1 · shares: Represents a deferred stock award of 2,300 restricted stock units which vests on December 31, 2017. This retainer award was granted in lieu and satisfaction of the annual cash retainer compensation to be earned by the director for his service on the board and a committee of the Issuer's Board of Directors during 2017. The number of shares of common stock subject to such retainer award is equal to the amount of cash that would have been received had the applicable retainer all been paid in cash, divided by the average daily closing market price of the Issuer's common stock for the month of August, rounded to the nearest 100 shares. F2 · balance_after: Includes a deferred stock award of 2,300 restricted stock units which vests on December 31, 2017. Read SEC document |
| October 30, 2017 Filed Nov 1, 2017 21:09 UTC | HARVARD BIOSCIENCE INC HBIO · Entity 7369 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 87,600 | $0.00 Strike: $3.33 | $0.00 |
DisclosureSEC source: 0001209191-17-058644 · doc4.xml · derivative · entry 2 Loewald Thomas W · CIK 0001538555 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,600 Underlying: Common Stock, par value $0.01 per share · 87,600 shares Expires 2027-10-30 F3 · derivative.exercise_date: The options vest in three equal installments on October 30, 2018, 2019 and 2020. Read SEC document |
| August 28, 2017 Filed Aug 29, 2017 22:45 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | Tax withholdingCommon Stock | 410 | $178.43 | $73,156.30 |
DisclosureSEC source: 0001127602-17-026675 · form4.xml · nonDerivative · entry 1 Loewald Thomas W · CIK 0001538555 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,133 Read SEC document |
| August 25, 2017 Filed Aug 28, 2017 22:06 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | Tax withholdingCommon Stock | 974 | $177.22 | $172,612.28 |
DisclosureSEC source: 0001127602-17-026580 · form4.xml · nonDerivative · entry 3 Loewald Thomas W · CIK 0001538555 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,543 Read SEC document |
| August 25, 2017 Filed Aug 28, 2017 22:06 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | Tax withholdingCommon Stock | 960 | $177.22 | $170,131.20 |
DisclosureSEC source: 0001127602-17-026580 · form4.xml · nonDerivative · entry 2 Loewald Thomas W · CIK 0001538555 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,517 Read SEC document |
| August 24, 2017 Filed Aug 28, 2017 22:06 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | Tax withholdingCommon Stock | 800 | $175.96 | $140,768.00 |
DisclosureSEC source: 0001127602-17-026580 · form4.xml · nonDerivative · entry 1 Loewald Thomas W · CIK 0001538555 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,477 Read SEC document |
| April 27, 2017 Filed Apr 28, 2017 21:00 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | SaleCommon Stock | 1,532 | $168.76 | $258,540.32 |
DisclosureSEC source: 0001127602-17-015870 · form4.xml · nonDerivative · entry 1 Loewald Thomas W · CIK 0001538555 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,277 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 3, 2017. Read SEC document |
| March 08, 2017 Filed Mar 9, 2017 21:13 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | Exercise / conversionStock Option (Right to Buy) · Derivative | 7,675 | $0.00 Strike: $73.24 | $0.00 |
DisclosureSEC source: 0001127602-17-011047 · form4.xml · derivative · entry 3 Loewald Thomas W · CIK 0001538555 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,675 shares Expires 2020-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested in four equal installments on February 26, 2014, 2015, 2016 and 2017. Read SEC document |
| March 08, 2017 Filed Mar 9, 2017 21:13 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | SaleCommon Stock | 7,675 | $157.39 | $1,207,968.25 |
DisclosureSEC source: 0001127602-17-011047 · form4.xml · nonDerivative · entry 2 Loewald Thomas W · CIK 0001538555 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,809 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 3, 2017. Read SEC document |
| March 08, 2017 Filed Mar 9, 2017 21:13 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | Exercise / conversionCommon Stock | 7,675 | $73.24 | $562,117.00 |
DisclosureSEC source: 0001127602-17-011047 · form4.xml · nonDerivative · entry 1 Loewald Thomas W · CIK 0001538555 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,484 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 06, 2017 Filed Mar 8, 2017 22:12 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | SaleCommon Stock | 4,049 | $158.71 | $642,616.79 |
DisclosureSEC source: 0001127602-17-010868 · form4.xml · nonDerivative · entry 1 Loewald Thomas W · CIK 0001538555 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,809 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 3, 2017. Read SEC document |
| February 28, 2017 Filed Mar 2, 2017 22:51 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | GrantStock Option (Right to Buy) · Derivative | 27,300 | $0.00 Strike: $157.68 | $0.00 |
DisclosureSEC source: 0001127602-17-009845 · form4.xml · derivative · entry 4 Loewald Thomas W · CIK 0001538555 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,300 Underlying: Common Stock · 27,300 shares Expires 2024-02-28 F2 · derivative.exercise_date: The option vests in four equal annual installments beginning on February 28, 2018. Read SEC document |
| February 28, 2017 Filed Mar 2, 2017 22:51 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | Tax withholdingCommon Stock | 1,301 | $157.68 | $205,141.68 |
DisclosureSEC source: 0001127602-17-009845 · form4.xml · nonDerivative · entry 3 Loewald Thomas W · CIK 0001538555 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,858 Read SEC document |
| February 28, 2017 Filed Mar 2, 2017 22:51 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | GrantCommon Stock | 5,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-009845 · form4.xml · nonDerivative · entry 2 Loewald Thomas W · CIK 0001538555 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,159 Read SEC document |
| February 28, 2017 Filed Mar 2, 2017 22:51 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | GrantCommon Stock | 8,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-009845 · form4.xml · nonDerivative · entry 1 Loewald Thomas W · CIK 0001538555 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,359 F1 · shares: Shares represent a performance-based restricted stock unit award granted on February 24, 2016. The Company's Compensation Committee determined on February 28, 2017, that the performance criteria related to this award was satisfied. One-third of the shares vested on February 28, 2017, one-third of the shares vest on February 28, 2018, and the remaining one-third vest on February 28, 2019. Read SEC document |
| February 24, 2017 Filed Feb 28, 2017 22:05 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | Tax withholdingCommon Stock | 939 | $158.98 | $149,282.22 |
DisclosureSEC source: 0001127602-17-008944 · form4.xml · nonDerivative · entry 2 Loewald Thomas W · CIK 0001538555 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,859 Read SEC document |
| February 24, 2017 Filed Feb 28, 2017 22:05 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | Tax withholdingCommon Stock | 1,016 | $158.98 | $161,523.68 |
DisclosureSEC source: 0001127602-17-008944 · form4.xml · nonDerivative · entry 1 Loewald Thomas W · CIK 0001538555 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,798 Read SEC document |
| August 29, 2016 Filed Aug 31, 2016 20:58 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | SaleCommon Stock | 3,256 | $152.28 | $495,823.68 |
DisclosureSEC source: 0001127602-16-061604 · form4.xml · nonDerivative · entry 1 Loewald Thomas W · CIK 0001538555 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,814 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 2, 2016. Read SEC document |
| August 26, 2016 Filed Aug 30, 2016 21:17 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | SaleCommon Stock | 913 | $151.92 | $138,702.96 |
DisclosureSEC source: 0001127602-16-061508 · form4.xml · nonDerivative · entry 2 Loewald Thomas W · CIK 0001538555 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,070 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 2, 2016. Read SEC document |
| August 26, 2016 Filed Aug 30, 2016 21:17 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | Tax withholdingCommon Stock | 2,894 | $152.36 | $440,929.84 |
DisclosureSEC source: 0001127602-16-061508 · form4.xml · nonDerivative · entry 1 Loewald Thomas W · CIK 0001538555 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,983 Read SEC document |
| August 25, 2016 Filed Aug 29, 2016 21:59 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | Tax withholdingCommon Stock | 812 | $151.35 | $122,896.20 |
DisclosureSEC source: 0001127602-16-061400 · form4.xml · nonDerivative · entry 1 Loewald Thomas W · CIK 0001538555 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,877 Read SEC document |
| August 24, 2016 Filed Aug 26, 2016 22:10 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | Tax withholdingCommon Stock | 480 | $151.26 | $72,604.80 |
DisclosureSEC source: 0001127602-16-061268 · form4.xml · nonDerivative · entry 1 Loewald Thomas W · CIK 0001538555 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,689 Read SEC document |
| July 13, 2016 Filed Jul 14, 2016 20:35 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | Exercise / conversionStock Option (Right to Buy) · Derivative | 8,025 | $0.00 Strike: $73.24 | $0.00 |
DisclosureSEC source: 0001127602-16-058002 · form4.xml · derivative · entry 3 Loewald Thomas W · CIK 0001538555 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,675 Underlying: Common Stock · 8,025 shares Expires 2020-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option is exercisable in four equal annual installments. The first, second and third installments became exercisable on February 26, 2014, 2015, and 2016, and the last installment becomes exercisable on February 26, 2017. Read SEC document |
| July 13, 2016 Filed Jul 14, 2016 20:35 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | SaleCommon Stock | 8,025 | $155.00 | $1,243,875.00 |
DisclosureSEC source: 0001127602-16-058002 · form4.xml · nonDerivative · entry 2 Loewald Thomas W · CIK 0001538555 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,169 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 2, 2016. Read SEC document |
| July 13, 2016 Filed Jul 14, 2016 20:35 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | Exercise / conversionCommon Stock | 8,025 | $73.24 | $587,751.00 |
DisclosureSEC source: 0001127602-16-058002 · form4.xml · nonDerivative · entry 1 Loewald Thomas W · CIK 0001538555 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,194 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 02, 2016 Filed Jun 6, 2016 20:39 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $73.24 | $0.00 |
DisclosureSEC source: 0001127602-16-054819 · form4.xml · derivative · entry 5 Loewald Thomas W · CIK 0001538555 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,700 Underlying: Common Stock · 10,000 shares Expires 2020-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option is exercisable in four equal annual installments. The first, second and third installments became exercisable on February 26, 2014, 2015, and 2016, and the last installment becomes exercisable on February 26, 2017. Read SEC document |
| June 02, 2016 Filed Jun 6, 2016 20:39 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $73.24 | $0.00 |
DisclosureSEC source: 0001127602-16-054819 · form4.xml · derivative · entry 4 Loewald Thomas W · CIK 0001538555 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,700 Underlying: Common Stock · 5,000 shares Expires 2020-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option is exercisable in four equal annual installments. The first, second and third installments became exercisable on February 26, 2014, 2015, and 2016, and the last installment becomes exercisable on February 26, 2017. Read SEC document |
| June 02, 2016 Filed Jun 6, 2016 20:39 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | SaleCommon Stock | 15,000 | $152.84 | $2,292,600.00 |
DisclosureSEC source: 0001127602-16-054819 · form4.xml · nonDerivative · entry 3 Loewald Thomas W · CIK 0001538555 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,169 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 2, 2016. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $152.38 to $153.30, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 02, 2016 Filed Jun 6, 2016 20:39 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | Exercise / conversionCommon Stock | 10,000 | $73.24 | $732,400.00 |
DisclosureSEC source: 0001127602-16-054819 · form4.xml · nonDerivative · entry 2 Loewald Thomas W · CIK 0001538555 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,169 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 02, 2016 Filed Jun 6, 2016 20:39 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | Exercise / conversionCommon Stock | 5,000 | $73.24 | $366,200.00 |
DisclosureSEC source: 0001127602-16-054819 · form4.xml · nonDerivative · entry 1 Loewald Thomas W · CIK 0001538555 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,169 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 03, 2016 Filed Mar 5, 2016 00:15 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | Exercise / conversionStock Option (Right to Buy) · Derivative | 3,625 | $0.00 Strike: $49.49 | $0.00 |
DisclosureSEC source: 0001127602-16-045146 · form4.xml · derivative · entry 3 Loewald Thomas W · CIK 0001538555 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,625 shares Expires 2017-03-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested in four equal installments on March 5, 2012, 2013, 2014 and 2015. Read SEC document |
| March 03, 2016 Filed Mar 5, 2016 00:15 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | SaleCommon Stock | 3,625 | $137.28 | $497,640.00 |
DisclosureSEC source: 0001127602-16-045146 · form4.xml · nonDerivative · entry 2 Loewald Thomas W · CIK 0001538555 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,169 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 2, 2016. Read SEC document |
| March 03, 2016 Filed Mar 5, 2016 00:15 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | Exercise / conversionCommon Stock | 3,625 | $49.49 | $179,401.25 |
DisclosureSEC source: 0001127602-16-045146 · form4.xml · nonDerivative · entry 1 Loewald Thomas W · CIK 0001538555 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,794 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 26, 2016 Filed Mar 1, 2016 22:26 UTC | THERMO FISHER SCIENTIFIC INC. TMO · Entity 2836 | Tax withholdingCommon Stock | 743 | $130.71 | $97,117.53 |
DisclosureSEC source: 0001127602-16-044238 · form4.xml · nonDerivative · entry 1 Loewald Thomas W · CIK 0001538555 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,169 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.